Status:
COMPLETED
Triadic Expectations: Decision Making in the Context of Cancer Treatment
Lead Sponsor:
Duke University
Conditions:
Health Care Decision Making
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this pilot study is to test the feasibility of identifying and interviewing healthcare triads (patients, loved ones and oncologists) in a research study and evaluate the influences of p...
Detailed Description
The overall goal of this study is to evaluate the influences of oncologists and patients' loved ones on cancer treatment decision-making. The specific aims are: AIM 1: Test the feasibility of identif...
Eligibility Criteria
Inclusion
- Oncologist Inclusion Criteria:
- At least 18 years of age;
- An attending physician or fellow at Duke University Medical Center;
- Medical, surgical or radiation oncologist;
- Provides care to patients diagnosed with at least one of the following conditions:
- Recurrent or refractory Acute Myeloid Leukemia (AML), also known as acute myelogenous leukemia or acute nonlymphocytic leukemia (ANLL);
- Chronic myeloid leukemia (CML) in blast phase;
- Non-hodgkin lymphoma (NHL), relapsed or refractory;
- Acute lymphocytic leukemia (ALL), relapsed or refractory;
- Metastatic pancreatic cancer;
- Metastatic colorectal cancer;
- Metastatic gastro-esophageal cancer;
- Metastatic Cholangiocarcinoma.
- Patient Inclusion Criteria:
- At least 18 years of age;
- A Duke patient receiving care from an oncology provider who is enrolled in the study;
- Currently admitted to the Duke University hematological malignancies in-patient service OR being seen at Duke's outpatient GI cancer clinic;
- Made a cancer treatment decision in the last 3 months;
- Diagnosed with one of the following:
- Recurrent or refractory Acute Myeloid Leukemia (AML), also known as acute myelogenous leukemia or acute nonlymphocytic leukemia (ANLL);
- Chronic myeloid leukemia (CML) in blast phase;
- Non-hodgkin lymphoma (NHL), relapsed or refractory;
- Acute lymphocytic leukemia (ALL), relapsed or refractory;
- Metastatic pancreatic cancer;
- Metastatic colorectal cancer;
- Metastatic gastro-esophageal cancer;
- Metastatic Cholangiocarcinoma.
- Loved One (friend/family) Inclusion Criteria:
- At least 18 years of age;
- Identified by patient as influential in a recent (within 3 months) treatment decision;
- Able and willing to complete the study interview in person or by telephone.
- Exclusion for all Subjects:
- Lacking capacity to give legally effective consent;
- Does not read or understand English.
Exclusion
Key Trial Info
Start Date :
August 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT01898481
Start Date
August 1 2013
End Date
December 1 2013
Last Update
February 6 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University
Durham, North Carolina, United States